Cuantificación de metales en LECISAN®por espectrometría de emisión óptica con plasma acoplado inductivamente

Introducción: La contaminación resultante de la industrialización ha propiciado el aumento de la concentración de metales en diversos ambientes y su incorporación a materias primas y productos terminados, lo que repercute directamente en la salud humana. Objetivo: Cuantificar metales en la materia prima empleada en la fabricación de la tableta masticable LECISAN® y en la tableta, para establecer niveles de referencia de: aluminio, calcio, cadmio, cromo, cobre, hierro, magnesio, plomo, silicio, vanadio y zinc. Método: Se utilizó la espectrometría atómica de emisión óptica con plasma inductivamente acoplado (ICP OES) y se establecieron mediante métodos estadísticos los intervalos de confianza para la media de los valorescuantificados con una probabilidad del 95%. Resultados: Existen diferencias significativas entre las dos formas de presentación en cuanto a la cantidad de todos los metales, excepto aluminio (p<0,05). Los coeficientes de variación fueron bajos, el cromo obtuvo un valor cercano al 10% en la materia prima y el plomo resultó elevado (17,44 %). Los valores se encuentran dentro del rango reportado como permisibles según norma cubana (NC 493:2012) excepto para plomo y cobre. Se observaron mayores concentraciones de aquellos elementos con efectos favorables para la salud. Conclusiones: Los resultados encontrados deben ser considerados como referenciales para la evaluación del impacto que sobre la salud tendría el régimen de administración diaria del suplemento nutricionalLECISAN® yel análisis de factores relacionados con la presencia de metales en subproductos del refinado del aceite de soya para futura investigaciones.

Introduction: The pollution resulting from industrialization has led to an increase in the concentration of metals in various environments and their incorporation into raw materials and finished products, which has a direct impact on human health. Objective: To quantify metals in the raw material used in the manufacture of the LECISAN® chewable tablet and in the tablet, to establish reference levels of: aluminum, calcium, cadmium, chromium, copper, iron, magnesium, lead, silicon, vanadium and zinc. Method: Atomic optical emission spectrometry with inductively coupled plasma (ICP OES) was used and confidence intervals for the mean of the quantified values were established using statistical methods with a probability of 95%. Results: There are significant differences between the two presentation forms in terms of the amount of all metals, except aluminum (p<0.05). The variation coefficients were low, chromium obtained a value close to 10% in the raw material and lead was high (17.44%). The values are within the range reported as permissible according to Cuban standards (NC 493:2012) except for lead and copper. Higher concentrations of those elements with favorable health effects were observed. Conclusions: The results found should be considered as references for the evaluation of the impact that the daily administration regimen of the LECISAN® nutritional supplement would have on health and the analysis of factors related to the presence of metals in by-products of soybean oil refining for future research.

Introdução: A poluição decorrente da industrialização tem levado ao aumento da concentração de metais em diversos ambientes e à sua incorporação em matérias-primas e produtos acabados, o que tem impacto direto na saúde humana. Objetivo: Quantificar metais na matéria-prima utilizada na fabricação do comprimido mastigável LECISAN® e no comprimido, estabelecer teores de referência de: alumínio, cálcio, cádmio, cromo, cobre, ferro, magnésio, chumbo, silício, vanádio e zinco. Método: Foi utilizada espectrometria de emissão óptica atômica com plasma indutivamente acoplado (ICP OES) e os intervalos de confiança para a média dos valores quantificados foram estabelecidos por meio de métodos estatísticos com probabilidade de 95%. Resultados: Existem diferenças significativas entre as duas formas de apresentação quanto à quantidade de todos os metais, exceto alumínio (p<0,05). Os coeficientes de variação foram baixos, o cromo obteve valor próximo a 10% na matéria-prima e o chumbo foi alto (17,44%). Os valores estão dentro da faixa informada como permitida segundo as normas cubanas (NC 493:2012) exceto para chumbo e cobre. Foram observadas concentrações mais elevadas desses elementos com efeitos favoráveis à saúde. Conclusões: Os resultados encontrados devem ser considerados referências para a avaliação do impacto que o regime diário de administração do suplemento nutricional LECISAN® teria na saúde e a análise dos fatores relacionados à presença de metais em subprodutos do refino do óleo de soja para pesquisas futuras.

Pharmacodynamic and Pharmacokinetic Evaluation of Soy Lecithin Based Tablet of Boswellic Acid

Background: The oleo-gum resin of Boswellia serrata contains pentacyclic triterpenic acids known as Boswellic acids (BAs) that are responsible for the anti-inflammatory and anti-arthritic activities by inhibition of 5-lipoxygenase. Methods: Soylecithin based tablet formulation of an enriched extract of BAs were formulated and evaluated comparatively with the unformulated extract for bioavailability on rabbits and therapeutic efficacy against arthritis on rats targeting two primary constituent 11-keto ?-boswellic acid (KBA) and 3-O-acetyl 11-keto ?-boswellic acid (AKBA). Total BAs content in the enriched fraction was measured and characterized by HPLC analysis. Soy lecithin based tablet of BAs enriched extract was prepared and evaluated for different parameters. Tablets at 160 and 320 mg/kg, and unformulated extract 160 mg/kg was assessed on CFA-induced arthritic rat model and bioavailability was evaluated on the rabbit. Results: Tablet formulation showed two times higher efficacy in increasing hot plate reaction time, reduction in paw volume, and TNF-? levels compared to unformulated extract signifying enhanced systemic absorption and availability of the BAs at the site of action. The tablet at 320 mg/kg dose showed repair of articular surfaces with small areas of erosion and irregularities in the connective tissue. Plasma samples of rabbit showed identified peaks only for KBA. Conclusion: The soy lecithin based tablet of BAs enriched extract at both doses showed higher peak plasma concentration and AUC compared to unformulated enriched extract. The results of the study substantiated higher efficacy and bioavailability of B. serrata gum resin enriched extract in the form of lecithin based tablet formulation.

LECISAN® y sus potencialidades terapéuticas para el abordaje farmacológico de la obesidad / LECISAN® and its therapeutic potentialities for the pharmacological approach to obesity

Introducción: La obesidad se ha identificado como un estado crónico de inflamación sistémica conocido como lipoinflamación. En los últimos tiempos ha cobrado relevancia el descubrimiento de moléculas clave que actúan como blancos terapéuticos, así como sus conexiones y mecanismos existentes. Por otra parte, es sabido lo difícil que es la obtención de nuevos fármacos naturales como alternativas o terapias complementarias en enfermedades crónicas no transmisibles como la obesidad y las dislipemias. El LECISAN® destaca como candidato por sus potencialidades. Objetivos: Valorar los resultados de investigaciones preclínicas y clínicas que avalan el uso del LECISAN®. Métodos: Se realizó una revisión sistemática y crítica de las evidencias de impacto de los efectos de la lecitina de soya. Se consultaron artículos publicados preferentemente en los últimos diez años en las bases de datos EBSCO, Google Scholar, Latindex, Redalyc, DOAJ, Dialnet, WorldCat, LILACS, SciELO y OATD. Conclusiones: El LECISAN® es un producto natural que rebasa el contexto de su empleo como suplemento nutricional, pero requiere nuevas investigaciones en el campo de la farmacología. Resultan contradictorios y poco concluyentes los resultados referentes a sus posibles efectos y usos(AU)

Introduction: Obesity has been identified as a chronic state of systemic inflammation known as lipoinflammation. In recent times, the discovery of key molecules acting as therapeutic targets, as well as their connections and existing mechanisms, has gained relevance. On the other hand, it is known how difficult it is to obtain new natural drugs as alternatives or complementary therapies in chronic noncommunicable diseases such as obesity and dyslipidemias. LECISAN® stands out as a candidate, for its potentialities. Objective: To assess the results of preclinical and clinical investigations that support the use of LECISAN®. Methods: A systematic and critical review of evidence about the impact of the effects of soy lecithin was carried out. Articles published preferably in the last ten years were consulted, from the EBSCO, Google Scholar, Latindex, Redalyc, DOAJ, Dialnet, WorldCat, LILACS, SciELO and OATD databases. Conclusions: LECISAN® is a natural product that goes beyond the context of its use as a nutritional supplement, but requires new research in the field of pharmacology. The results regarding its possible effects and uses are contradictory and inconclusive, based on hypotheses that relate an emulsifying action with the phospholipids present in the mixture, the antioxidant effects with isoflavones, the anti-inflammatory effects with the polyunsaturated fatty acids that regulate lipid metabolism, as well as the activation of the phospholipase A2 system with the consequent production of inflammatory cytosines(AU)

Beef tallow and emulsifier in growing-finishing pig diets

ABSTRACT Two trials were aimed to evaluate beef tallow in diets with and without emulsifier on performance of pigs at growing-finishing phases. In the first trial, 15 barrows (22.03±0.62 kg) were distributed among three treatments: reference diet; test diet 1 (5% beef tallow) and test diet 2 (10% beef tallow). Beef tallow presented average value of 7130.97 kcal ME/kg. For the performance trail, 30 barrows (24.85±1.18 kg) were distributed among five treatments: T1 - diet with soybean oil and 3230 kcal ME /kg; T2 - diet with beef tallow and 3230 kcal ME/kg; T3 - diet with beef tallow and 3080 kcal ME/kg; T4 - diet with beef tallow, 3080 kcal/kg and 0.1% emulsifier; T5 - diet with beef tallow, 2930 kcal ME/kg and 0.1% emulsifier. Feed conversion was worse in animals fed diet with 3080 kcal ME/kg containing beef tallow and with 2930 kcal ME/kg with beef tallow and emulsifier. For economic availability, animals fed diet with beef tallow and 3230 kcal ME/kg and those fed diet with 3080 kcal ME/kg containing beef tallow and emulsifier, did not differ from animals fed diet with soybean oil, which enables the reduction up to 150 kcal ME/kg be compensated by emulsifier addition.

Efeito da utilização de diferentes diluidores para a produção in vitro de embriões bovinos / Effect of different bovine semen extenders on in vitro development of bovine embryos

Objetivou-se avaliar as características morfológica e funcional do sêmen bovino congelado comparando-se a eficácia de dois diferentes diluidores. O ejaculado de quatro touros foi dividido em duas partes iguais, uma submetida ao diluidor Tris e gema de ovo (A) e outra ao diluidor à base de lecitina de soja (Andromed®) (B). No experimento I, cinco palhetas dos diluidores A e B de cada touro foram descongeladas e avaliadas quanto à motilidade, vigor, concentração, morfologia espermática e teste de termor-resistência lento. Foram feitas, ainda, avaliação da integridade de membranas, por meio da associação das sondas iodeto de propídio, isotiocionato de fluoresceína - Pisum sativum e carbocianina catiônica lipofílica, e avaliação funcional da membrana plasmática com teste hiposmótico. A avaliação da integridade da cromatina foi realizada pelo método de coloração com laranja de acridina. No experimento II, o sêmen com os diferentes diluidores foi utilizado na fecundação in vitro, sendo observadas taxas de clivagem e desenvolvimento embrionário in vitro. Em relação aos resultados obtidos, apenas a porcentagem de espermatozoides no sêmen congelado foi discretamente maior com o diluidor A, concluindo-se que o diluidor composto por lecitina de soja pode substituir o composto por Tris e gema de ovo, respeitando-se as variações individuais de cada touro utilizado no presente experimento.

The goal of this study was to evaluate the protective effect of egg yolk compared with a soybean lecithin-based extender on morphologic and functional characteristics of frozen bovine semen. The ejaculate of four bulls was divided into two equal parts, one diluted with egg-yolk-Tris extender (A) and the other with a soy-lecithin based extender (Andromed®) (B). In experiment I, five straws of extender A and B from each bull were thawed and assessed regarding motility (subjective and computerized analysis), vigor, concentration, sperm morphology and slow thermoresistance (STR), evaluation of membrane integrity through association of propidium iodite probes (PI), fluorescein isotiocianate - Pisum sativum (FITC-PSA) and lipophilic cationic carbocyanine (JC-1) and functional evaluation of the plasmatic membrane through Hyposmotic Swelling Test (HOST). An evaluation of chromatin integrity was performed with the acridine orange staining procedure. In experiment II, the frozen semen with different extenders was used for in vitro fertilization (IVF), analyzing cleavage rates and in vitro embryo development. No statistical difference between extenders was identified, suggesting that the soy lecithin extender may substitute egg-yolk-Tris extender, considering the individual variations of each bull used in this experiment.

Efeito da Lecitina de Soja sobre os Lipídeos e Proteína C reativa e na prevenção da Hipertrofia Ventricular Esquerda de Camundongos Hiperlipidêmicos / Effect of soy lecithin on lipids and C-reactive protein and the prevention of Left Ventricular Hypertrophy in hyperlipidemic mice

A regulação do metabolismo lipídico com drogas ou alimentos naturais é um alvo importante para diminuir o risco de doenças cardiovasculares. O objetivo deste estudo foi verificar o efeito da lecitina de soja na dislipidemia e na hipertrofia ventricular de camundongos hipercolesterolêmicos. Utilizaram-se quatro grupos de camundongos LDLr-/- com 3 meses de idade que receberam a seguintes dietas: Grupo S- ração padrão; Grupo S+Lec- ração padrão e lecitina de soja; Grupo HL- ração hiperlipídica; e Grupo HL+Lec- ração hiperlipídica e lecitina de soja. Após 15 dias, o sangue foi coletado para análise sérica dos lipídeos e da proteína C reativa. O ventrículo esquerdo foi separado, a proporção peso ventricular (mg) pelo peso do animal (g) foi calculada e, em seguida, processado histologicamente. Cortes histológicos foram corados com hematoxilina/eosina e picrosírius red para avaliar alterações morfológicas e morfométricas ventriculares. A lecitina de soja apresentou efeito antidislipidêmico e aumentou os níveis séricos de HDL nos camundongos do grupo S+Lec. Entretanto, nos camundongos do grupo HL+lec, a lecitina de soja não preveniu a dislipidemia, apenas aumentou o nível sérico do HDL. Este efeito nestes animais influenciou no processo inflamatório cardiovascular, reduzindo o nível sérico de proteína C reativa; e prevenindo a hipertrofia ventricular esquerda. A utilização da lecitina de soja representa um tratamento e/ou uma prevenção alternativa de baixo custo para as dislipidemias não associadas com dieta hiperlipídica. Contudo, a lecitina de soja aumenta os níveis séricos do HDL prevenindo o desenvolvimento da HVE mesmo em dislipidemias associadas com dieta hiperlipídica.

The regulation of lipid metabolism with drugs or natural foods is an important target for reducing the risk of cardiovascular disease. The aim of this study was to investigate the effects of soy lecithin on left ventricular hypertrophy (LVH) and dyslipidemia in hypercholesterolemic mice. We used four experimental groups of LDLr-/- mice (aged 3 months), which received the following diets: Group S: standard diet, Group S+Lec: standard diet and soy lecithin; Group HL: hyperlipidic diet and Group HL+Lec: hyperlipidic diet and soy lecithin. After 15 days on these diets, blood was collected for analysis of serum lipids and C-reactive protein. The left ventricle was dissected out and weighed and the ratio of its weight to the body weight of the animal was calculated, after which it was processed histologically. Sections were stained with hematoxylin-eosin and picrosirius red, to assess morphological and morphometric changes in the ventricle. In Group S+Lec, the soy lecithin had an antidyslipidemic effect and enhanced the serum levels of HDL. However, in the mice in group HL+Lec, soy lecithin did not prevent dyslipidemia, only increasing the serum level of HDL. These effects in these animals influenced the cardiovascular inflammatory process, reducing the level of serum C-reactive protein and preventing LVH. Soy lecithin could thus be used as a treatment or a low-cost alternative preventative measure against dyslipidemia associated with a non-fat diet. However, soy lecithin increases the serum level of HDL, reducing the risk of LVH even in dyslipidemia associated with a high-fat diet.